Tumor Suppressor p53-Mediated Structural Reorganization of the Transcriptional Coactivator p300
- PMID: 31314496
- DOI: 10.1021/acs.biochem.9b00333
Tumor Suppressor p53-Mediated Structural Reorganization of the Transcriptional Coactivator p300
Abstract
Transcriptional coactivator p300, a critical player in eukaryotic gene regulation, primarily functions as a histone acetyltransferase (HAT). It is also an important player in acetylation of a number of nonhistone proteins, p53 being the most prominent one. Recruitment of p300 to p53 is pivotal in the regulation of p53-dependent genes. Emerging evidence suggests that p300 adopts an active conformation upon binding to the tetrameric p53, resulting in its enhanced acetylation activity. As a modular protein, p300 consists of multiple well-defined domains, where the structured domains are interlinked with unstructured linker regions. A crystal structure of the central domain of p300 encompassing Bromo, RING, PHD, and HAT domains demonstrates a compact module, where the HAT active site stays occluded by the RING domain. However, although p300 has a significant role in mediating the transcriptional activity of p53, only a few structural details on the complex of these two full-length proteins are available. Here, we present a cryo-electron microscopy (cryo-EM) study on the p300-p53 complex. The three-dimensional cryo-EM density map of the p300-p53 complex, when compared to the cryo-EM map of free p300, revealed that substantial change in the relative arrangement of Bromo and HAT domains occurs upon complex formation, which is likely required for exposing HAT active site and subsequent acetyltransferase activity. Our observation correlates well with previous studies showing that the presence of Bromodomain is obligatory for effective acetyltransferase activity of HAT. Thus, our result sheds new light on the mechanism whereby p300, following binding with p53, gets activated.
Similar articles
-
Structural features of human histone acetyltransferase p300 and its complex with p53.FEBS Lett. 2012 Nov 2;586(21):3793-8. doi: 10.1016/j.febslet.2012.09.012. Epub 2012 Sep 23. FEBS Lett. 2012. PMID: 23010591
-
Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation.Cancer Res. 2007 Mar 1;67(5):2256-2264. doi: 10.1158/0008-5472.CAN-06-3985. Cancer Res. 2007. PMID: 17332356 Free PMC article.
-
The structural basis of protein acetylation by the p300/CBP transcriptional coactivator.Nature. 2008 Feb 14;451(7180):846-50. doi: 10.1038/nature06546. Nature. 2008. PMID: 18273021
-
Recent Advances in the Development of CBP/p300 Bromodomain Inhibitors.Curr Med Chem. 2020;27(33):5583-5598. doi: 10.2174/0929867326666190731141055. Curr Med Chem. 2020. PMID: 31364510 Review.
-
Current development of CBP/p300 inhibitors in the last decade.Eur J Med Chem. 2021 Jan 1;209:112861. doi: 10.1016/j.ejmech.2020.112861. Epub 2020 Oct 1. Eur J Med Chem. 2021. PMID: 33045661 Review.
Cited by
-
Make the right measurement: Discovery of an allosteric inhibition site for p300-HAT.Struct Dyn. 2019 Oct 11;6(5):054702. doi: 10.1063/1.5119336. eCollection 2019 Sep. Struct Dyn. 2019. PMID: 31649965 Free PMC article.
-
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.Cancer Commun (Lond). 2024 Mar;44(3):297-360. doi: 10.1002/cac2.12520. Epub 2024 Feb 4. Cancer Commun (Lond). 2024. PMID: 38311377 Free PMC article. Review.
-
The CDK4/6 Inhibitor Palbociclib Induces Cell Senescence of High-grade Serous Ovarian Cancer Through Acetylation of p53.Biochem Genet. 2024 Dec;62(6):5115-5128. doi: 10.1007/s10528-024-10704-w. Epub 2024 Feb 22. Biochem Genet. 2024. PMID: 38388849
-
Molecular basis for SOX2-dependent regulation of super-enhancer activity.Nucleic Acids Res. 2023 Dec 11;51(22):11999-12019. doi: 10.1093/nar/gkad908. Nucleic Acids Res. 2023. PMID: 37930832 Free PMC article.
-
Most Probable Druggable Pockets in Mutant p53-Arg175His Clusters Extracted from Gaussian Accelerated Molecular Dynamics Simulations.Protein J. 2022 Feb;41(1):27-43. doi: 10.1007/s10930-022-10041-0. Epub 2022 Jan 31. Protein J. 2022. PMID: 35099676
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous